Delivery Order SPE2DB20D3103-SPE2DB25FQ2X7
- Not listed
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $1,670.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded on July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that maintains an extensive portfolio of products...
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $33.5K delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) under a firm fixed-price contract with a completion date of September 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical and medical supply vendor for federal healthcare procurement. The order was placed to the company's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered...
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,281.17 to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5mL) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adacel TDAP syringes (0.5mL) valued at $1,072.00. The contract employs firm fixed price pricing with a completion date of August 26, 2025, and is classified as a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value transaction...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Adacel TDAP syringes (5-pack unit). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Adacel TDAP vaccine delivery supports the Department of...
- This delivery order from the Defense Logistics Agency Troop Support Medical (DLA) awards Amerisourcebergen Drug Corp $6,029.74 to supply 4561991182 ADACEL TDAP SYRINGE 5S on a firm fixed price basis. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. The prime contractor is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor, with no subcontractors indicated. As the DLA supports the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2X7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime vendor under the DLA's global pharmaceutical support vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for TDAP syringes supports the military healthcare supply chain and demonstrates the company's role in providing essential immunization and medical commodities to Defense Department stakeholders and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/12/25 |